Fibrosis Completed Phase 3 Trials for Peginterferon alfa-2b (DB00022)

Also known as: Fibrosis (morphologic abnormality) / Fibrosis (qualifier value) / Fibrosis NOS

IndicationStatusPhase
DBCOND0012375 (Fibrosis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00039871PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to Alpha-Interferon Plus Ribavirin (Study P02370)Treatment